ATRS - Antares Pharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Antares Pharma, Inc.

100 Princeton South
Suite 300
Ewing, NJ 08628
United States
609-359-3020
http://www.antarespharma.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees165

Key Executives

NameTitlePayExercisedYear Born
Mr. Robert F. AppleCEO, Pres & Director895.04k278.81k1966
Mr. Fred M. PowellExec. VP & CFO559.42kN/A1961
Mr. Peter J. GrahamExec. VP of HR, Gen. Counsel, Chief Compliance Officer & Corp. Sec.585.41kN/A1967
Dr. James Patrick TursiExec. VP, Head of R&D and Chief Medical Officer516.48kN/A1965
Mr. Patrick MadsenSr. VP of OperationsN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company's injection products include OTREXUP that comprises of pre-filled methotrexate syringe and VIBEX self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; XYOSTED for the treatment of testosterone deficiency in adult males; Sumatriptan Injection USP for the acute treatment of migraine and cluster headache in adults. Its injection products also comprise Epinephrine Injection USP for treating Anaphylaxis; Makena auto injectors to reduce the risk of preterm birth in women pregnant with a single baby; ZOMAJET and Twin-Jector EZ II Needle-free Injectors to administer human growth hormone for patients with growth retardation. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; and QuickShot auto injectors. It has strategic alliances with Teva Pharmaceutical Industries, Ltd., AMAG Pharmaceuticals, Inc., and Pfizer Inc. The company was founded in 1978 and is headquartered in Ewing, New Jersey.

Corporate Governance

Antares Pharma, Inc.’s ISS Governance QualityScore as of October 4, 2019 is 5. The pillar scores are Audit: 2; Board: 5; Shareholder Rights: 7; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.